期刊文献+

中性粒细胞与淋巴细胞比值和终末期肝病联合血清钠评分对乙型肝炎病毒相关慢加急性肝衰竭患者预后评估的分析 被引量:4

Evaluation of neutrophil/lymphocyte ratio and the end-stage liver disease-sodium model in predicting short-term prognosis of patients with HBV-related acute-on-chronic liver failure
原文传递
导出
摘要 目的探讨中性粒细胞/淋巴细胞比值(NLR)和终末期肝病联合血清钠(MELD-Na)评分在乙型肝炎病毒相关慢加急性肝衰竭(HBV-ACLF)患者短期预后评估中的应用价值。方法回顾性分析2019年1月至2021年12月杭州市西溪医院连续收治的234例HBV-ACLF患者的临床资料,其中男性194例、女性40例,年龄23~85岁。入院后12周内(短期)预后差者93例(预后差组)、临床治愈与临床好转者141例(生存组)。比较两组一般情况、外周血常规及NLR、病毒检测及肝功能各项指标等;采用单因素及多因素logistic回归分析影响HBV-ACLF患者短期预后的相关因素,绘制受试者工作特征(ROC)曲线、计算其曲线下面积;建立NLR与MELD-Na评分二者联合的logistics回归模型,观察其对HBV-ACLF患者预后判断的价值。结果生存组与预后差组患者年龄[(48.7±11.9)和(52.5±9.9)岁,t=-2.59,P=0.011]、男性比例[78.0%(110/141)和90.3%(84/93),χ^(2)=5.99,P=0.014]、总胆红素[202.9(141.2,287.6)和320.0(224.4,400.0)μmol/L,Z=-5.14,P<0.001]、血肌酐[71.0(59.0,78.0)和81.0(64.0,111.0)μmol/L,Z=-3.98,P<0.001]、国际标准化比值[1.66(1.52,1.86)和1.91(1.66,2.27),Z=-5.46,P<0.001]、外周血白细胞计数[5.16(3.99,6.95)×10^(9)/L和6.57(4.83,8.30)×10^(9)/L,Z=-4.14,P=0.001]、NLR[2.77(2.02,3.55)和5.48(3.44,8.53),Z=-8.48,P<0.001]、终末期肝病评分[22.0(20.0,24.0)和26.0(24.0,29.0),Z=-9.22,P<0.001]、MELD-Na评分[22.8(20.0,25.6)和29.0(25.0,36.0),Z=-9.16,P<0.001]、肝硬化比例[77.3%(109/141)和88.2%(82/93),χ^(2)=4.41,P=0.036]、肝肾综合征比例[2.8%(4/141)和12.9%(12/93)例,χ^(2)=8.91,P=0.003]及人工肝治疗比例[14.9%(21/141)和25.8%(24/93)例,χ^(2)=4.30,P=0.038]差异有统计学意义。logistic回归分析显示NLR(OR=3.76,95%CI:2.10~6.74,P<0.001)和MELD-Na评分(OR=2.24,95%CI:1.17~4.29,P=0.015)是影响HBV-ACLF患者入院后12周预后的独立危险因素。NLR和MELD-Na评分对HBV-ACLF患者短期预后预测的ROC曲线下面积分别为0.792和0.822,二者联合logistic预测模型预测的ROC曲线下面积为0.858,预测价值优于单独应用NLR(Z=-3.04,P=0.001)或MELD-Na评分(Z=-2.16,P=0.031)的预测价值。根据二者联合logistic预测模型的最佳截断值0.04,将患者分为≥0.04组和<0.04组,两组患者的生存率分别为78.5%(124/158)和22.4%(17/76),≥0.04组生存率显著高于<0.04组(χ^(2)=67.47,P<0.001)。结论NLR和MELD-Na评分是影响HBV-ACLF患者短期预后的独立危险因素,二者联合的logistic回归模型的判断效能高于单独应用。 Objective To evaluate neutrophil/lymphocyte ratio(NLR)and the model for end-stage liver disease-sodium(MELD-Na)score in predicting short-term prognosis of patients with HBV-related acute-on-chronic liver failure(HBV-ACLF).Methods A total of 234 consecutive HBV-ACLF patients(194 males and 40 females,aged 23-85 years)admitted to Hangzhou Xixi Hospital from January 2019 to December 2021 were enrolled.According to the 12-week clinical outcomes,patients were divided into good prognosis group(n=141)and poor prognosis group(n=93).Univariate and multivariate Logistic regression were performed to identify independent risk factors for poor prognosis of HBV-ACLF patients.Receiver operating characteristics(ROC)curve was applied to evaluate the accuracy of risk factors in predicting short-term prognosis of HBV-ACLF patients.Results The age[(48.7±11.9)vs.(52.5±9.9)years old,t=-2.59,P=0.011],proportion of males[78.0%(110/141)vs.90.3%(84/93),χ^(2)=5.99,P=0.014],total bilirubin[202.9(141.2,287.6)vs.320.0(224.4,400.0)μmol/L,Z=-5.14,P<0.001],creatinine[71.0(59.0,78.0)vs.81.0(64.0,111.0)μmol/L,Z=-3.98,P<0.001],international normalized ratio[1.66(1.52,1.86)vs.1.91(1.66,2.27),Z=-5.46,P<0.001],leukocyte count[5.16(3.99,6.95)×10^(9)/L vs.6.57(4.83,8.30)×10^(9)/L,Z=-4.14,P=0.001],NLR[2.77(2.02,3.55)vs.5.48(3.44,8.53),Z=-8.48,P<0.001],MELD score[22.0(20.0,24.0)vs.26.0(24.0,29.0),Z=-9.22,P<0.001],MELD-Na score[22.8(20.0,25.6)vs.29.0(25.0,36.0),Z=-9.16,P<0.001],liver cirrhosis[77.3%(109/141)vs.88.2%(82/93),χ^(2)=4.41,P=0.036],hepatorenal syndrome[4/141(2.8%)vs.12/93(12.9%),χ^(2)=8.91,P=0.003]and the proportion of artificial liver treatment[21/141(14.9%)vs.24/93(25.8%),χ^(2)=4.30,P=0.038]were significantly elevated in poor prognosis group compared with survival group.Logistic regression analysis showed that NLR(OR=3.76,95%CI:2.10-6.74,P<0.001)and MELD-Na score(OR=2.24,95%CI:1.17-4.29,P=0.015)were independent risk factors for poor short-term prognosis of HBV-ACLF patients.The area under the ROC curve(AUC)of NLR,and MELD-Na for the short-term prognosis of HBV-ACLF patients was 0.792 and 0.822,respectively.The AUC of the combination of NLR with MELD-Na was 0.858,which was significantly higher than that of NLR(Z=-3.04,P=0.001)or MELD-Na score(Z=-2.16,P=0.031)alone.Based on the cut-off value of the combined model,patients were classified into high combined model score(≥0.04)group and low combined model score(<0.04)group,the survival rate of the high group was significantly higher than that of the low group(χ^(2)=67.47,P<0.001).Conclusions NLR and MELD-Na score are independent risk factors of the short-term prognosis of HBV-ACLF patients.The combination of NLR and MELD-Na score will be beneficial to predict the short-term prognosis of HBV-ACLF patients.
作者 刘斐 傅晓晴 刘春涛 武瑞 华乐 刘寿荣 Liu Fei;Fu Xiaoqing;Liu Chuntao;Wu Rui;Hua Le;Liu Shourong(Department of Severe Liver Disease,Hangzhou Xixi Hospital Affiliated to Zhejiang University School of Medicine,Hangzhou 310023,China;Statistics Office of Hangzhou Xixi Hospital Affiliated to Zhejiang University School of Medicine,Hangzhou 310023,China)
出处 《中华全科医师杂志》 2023年第1期62-68,共7页 Chinese Journal of General Practitioners
基金 浙江省医药卫生科技计划项目(2022KY276) 杭州市医药卫生科技计划项目(0020190542)。
关键词 肝炎病毒 乙型 肝功能衰竭 慢加急性肝衰竭 中性粒细胞/淋巴细胞比值 终末期肝病联合血清钠评分 Hepatitis B virus Liver failure Acute-on-chronic liver failure Neutrophil-to-lymphocyte ratio Model for end-stage liver disease-sodium score
  • 相关文献

参考文献4

二级参考文献39

共引文献373

同被引文献47

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部